What is Xarelto used for?
Xarelto (Rivaroxaban) is a blood thinner manufactured by Jannsen Pharmaceuticals. It is used to treat Atrial Fibruation (A-Fib)
What are the side effects of Xarelto?
Side effects of Xarelto include excessive bleeding and bruising. In rare cases, the bleeding can be severe and even deadly.
Have there been any Xarelto Lawsuits?
Xarelto, a popular anticoagulant medication, has been the subject of numerous lawsuits. Patients have alleged that the drug caused serious and irreversible side effects, such as uncontrollable bleeding, brain hemorrhage, and internal bleeding. There have been several lawsuits since Xarelto was introduced to the market, with claims asserting that the manufacturers, Bayer and Johnson & Johnson, did not adequately disclose the risk for these excessive bleeding events.
Xarelto, known scientifically as rivaroxaban, was first approved by the FDA in 2011. It quickly gained popularity as a blood thinner used to prevent blood clots and reduce the risk of stroke in patients with conditions such as atrial fibrillation, deep vein thrombosis, and pulmonary embolism. However, soon after its approval, reports of severe side effects began to emerge, prompting many patients to file lawsuits against the manufacturers.
The lawsuits often cite a lack of adequate warnings about the serious risks associated with Xarelto. Notably, the allegations in these lawsuits include claims of bleeding risks, lack of an antidote, and inadequate warnings about the drug’s safety. Some patients allege that they were not sufficiently informed of the potential for severe side effects, including bleeding risks, before taking the drug. Moreover, some lawsuits claim that Bayer and Janssen Pharmaceuticals did not conduct adequate clinical trials to ensure the drug’s safety.
In March 2019, a significant milestone in the history of Xarelto lawsuits was reached when Bayer and Johnson & Johnson agreed to settle approximately 25,000 lawsuits for $775 million. This settlement resolved a substantial portion of the then-outstanding Xarelto lawsuits, which claimed that the companies failed to warn about the risks associated with the medication.
Many of the remaining Xarelto lawsuits have been consolidated into a multidistrict litigation (MDL) in the Eastern District of Louisiana. An MDL is a legal procedure that allows multiple lawsuits to be grouped together and heard by a single judge. This helps to streamline the legal process and avoid conflicting rulings. As part of the MDL, the judge has set four bellwether trials, which are intended to provide guidance for the remaining cases.
The types of lawsuits filed include personal injury claims, wrongful death claims, and liability claims. The personal injury claims allege that the drug’s manufacturers failed to warn patients and doctors about the risks associated with taking the medication, leading to injuries such as internal bleeding and other complications. Wrongful death claims allege that the manufacturers’ failure to warn about the risks led to the death of a loved one. Liability claims assert that the manufacturers are responsible for the injuries suffered by patients who took the medication. In some cases, punitive damages are being sought to punish the manufacturers for their actions and to deter other companies from engaging in similar conduct in the future.
More information about Xarelto
Here are several Xarelto related websites:
- Xarelto-US.com – official website
- Rivaroxaban – Wikipedia
- Web MD – Xarelto